HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro

Virology

Volumn 263, Issue 1, 1999, Pages 55-69

  Das, Atze T ^a   Land, Aafke ^a   Braakman, Ineke ^a   Klaver, Bep ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033543964     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9898     Document Type: Article

References (52)

1. Auersperg N. Long-term cultivation of hypodiploid human tumor cells. J. Nat. Cancer Inst. 32:1964;135-163.
2. Back N. K. T., Nijhuis M., Keulen W., Boucher C. A. B., Oude Essink B. B., van Kuilenburg A. B. P., Van Gennip A. H., Berkhout B. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:1996;4040-4049.
3. Bates P. Chemokine receptors and HIV-1: An attactive pair. Cell. 86:1996;1-3.
4. Berkhout B., Das A. T. Similarity of chemokines charge and the V3 domain of the HIV-1 Env protein. Emerging Infect. Dis. 4:1998;335-336.
5. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
6. Braakman I., Hoover-Litty H., Wagner K. R., Helenius A. Folding of Influenza Hemagglutinin in the endoplasmic reticulum. J. Cell Biol. 114:1991;401-411.
7. Cao J., Park I.-W., Cooper A., Sodroski J. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70:1996;1340-1354.
8. Chesebro B., Wehrly K., Nishio J., Perryman S. Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70:1996;9055-9059.
9. Cordonnier A., Montagnier L., Emerman M. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature. 340:1989;571-574.
10. Daar E. S., Li L. X., Moudgil T., Ho D. D. High concentrations of recombinant soluble CD4 are required to neutralize primary humanimmunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA. 87:1990;6574-6578.
11. Das A. T., van Dam A. P., Klaver B., Berkhout B. Improved envelop function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology. 244:1998;552-562.
12. De Jong J.-J., Ronde de A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing (SI) phenotype: Analysis by single amino acid substitution. J. Virol. 66:1992;6777-6780.
13. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
14. Dimitrov D. S., Blumenthal R. Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1994;1956-1961.
15. Domingo E., Holland J. J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:1997;151-178.
16. Doms R. W., Peiper S. C. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology. 235:1997;179-190.
17. Dumonceaux J., Nisole S., Chanel C., Quivet L., Amara A., Baleux F., Briand P., Hazan U. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J. Virol. 72:1998;512-519.
18. Fauci A. S., Desrosiers R. C. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;587-636 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
19. Fenner F., Ratcliffe F. N. Myxomatosis. 1965;Cambridge University Press, Cambridge.
20. Freed E. O., Martin M. A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270:1995;23883-23886.
21. Fujita K., Silver J., Peden K. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1. J. Virol. 66:1992;4445-4451.
22. Jiang S. HIV-1 co-receptors binding. Nat. Med. 3:1997;367-368.
23. Kirn D., Hermiston T., McCormick F. ONYX-015: Clinical data are encouraging. Nat. Med. 4:1998;1341-1342.
24. Koken, S. E. C., and Berkhout, B.1994. Intracellular processing of the HIV-1 Euv protein is regulated in a cell-type dependent manner. InTranscriptional Regulation of the Human Immunodeficiency Virus, Ph.D. Thesis, pp. 25-43. University of Amsterdam, Amsterdam, The Netherlands.
25. Kolesnitchenko V., King L., Riva A., Tani Y., Korsmeyer S., Cohen D. I. A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis. J. Virol. 71:1997;9753-9763.
26. Koot M., Vos A. H. V., Keet R. P. M., de Goede R. E. Y., Dercksen M. W., Terpstra F. G., Coutinho R. A., Miedema F., Tersmette M. HIV-1 biological phenotype in long-termed infected individuals evaluated with an MT-2 cocultivation assay. AIDS. 6:1992;49-54.
27. Kozak S. L., Platt E. J., Madani N., Ferro F. E., Peden K., Kabat D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71:1997;873-882.
28. Kwong P. D., Wyatt R., Robinson J., Sweet R. W., Sodroski J., Hendrickson W. A. Structure of an HIV gp120 envelope glycoprotein in a complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
29. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 50:1987;975-985.
30. McFadden G. Even viruses can learn to cope with stress. Science. 279:1998;40-41.
31. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson J., Barbas C. F. III, Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:1995;101-109.
32. Moore J. P., Ho D. D. The consequences of viral adaptation to growth on transformed T cells. AIDS. 9:1995;S117-S136.
33. Myers, G, Korber, B, Hahn, B. H, Jeang, K.-T, Mellors, J. H, McCutchan, F. E, Henderson, L. E, and, Pavlakis, G. N. 1995, AnonymousTheoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
34. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
35. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.-L., Arenzana-Seisdedos F., Schwartz O., Heard J.-M., Clark-Lewis I., Legler D. F., Loetscher M., Baggioloni M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
36. Olshevsky U., Helseth E., Furman C., Li J., Haseltine W., Sodroski J. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:1990;5701-5707.
37. ELI. Virology. 185:1991;661-672.
38. Rizzuto C. D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P. D., Hendrickson W. A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
39. Robey F. A., Harris-Kelson T., Robert-Guroff M., Batinic D., Ivanov B., Lewis M. S., Roller P. P. A synthetic conformational epitope from the C4 domain of HIV gp120 that binds CD4. J. Biol. Chem. 271:1996;17990-17995.
40. Sato H., Orenstein J., Dimitrov D., Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 186:1992;712-724.
41. Shahabuddin M., Bentsman G., Volsky B., Rodriguez I., Volsky D. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. J. Virol. 70:1996;7992-8002.
42. Shisler J. L., Senkevich T. G., Berry M. J., Moss B. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science. 279:1998;102-104.
43. Sullivan N., Sun Y., Li J., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell-line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:1995;4413-4422.
44. Thiriart C., Francotte M., Cohen J., Collognon C., Delers A., Kummert S., Molitor C., Gilles D., Roelants P., van Wijnendaele F., de Wilde M., Bruck C. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120. J. Immunol. 143:1989;1832-1836.
45. Verhoef K., Koper M., Berkhout B. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology. 237:1997;228-236.
46. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 40:1985;9-17.
47. Wain-Hobson S., Vartanian J.-P., Henry M., Chenciner N., Cheynier R., Delassus S., Pedroza Martins L., Sala M., Nugeyre M. T., Guétard D., Klatzmann D., Gluckman J.-C., Rozenbaum W., Barré-Sinoussi F., Montagnier L. LAV revisited: Origins of the early HIV-1 isolates from Institut Pasteur. Science. 252:1991;961-965.
48. Wang W.-K., Essex M., Lee T.-H. Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert. J. Virol. 70:1996;607-611.
49. Willey R. L., Ross E. K., Buckler-White A. J., Theodore T. S., Martin M. A. Functional interaction of constant and variable domains of human immunodeficiency virus type gp120. J. Virol. 63:1989;3595-3600.
50. Wrin T., Loh T. P., Charron Vennari J., Schuitemaker H., Nunberg J. H. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:1995;39-48.
51. Zaitseva A. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nat. Med. 3:1997;1369-1375.
52. Zhang Y., Fredriksson R., McKeating J. A., Fenyo E. M. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization. Virology. 238:1997;254-264.